Noven About
Noven: More
on Noven
Noven Pharmaceuticals, Inc., headquartered
in Miami, Florida, is a leading developer
of advanced transdermal drug delivery
technologies and prescription transdermal
products. Noven’s prescription patches
are sold in over 30 countries, and a range
of new patches are being developed in
collaboration with Novartis Pharma AG,
Shire Pharmaceuticals Group plc, P&G Pharmaceuticals,
Endo Pharmaceuticals Inc. and others.
Together with Novartis Pharmaceuticals
Corporation, Noven owns Novogyne Pharmaceuticals,
a profitable women’s health products company
with 2003 sales of over $100 million.
Among other products, Novogyne markets
and sells Noven’s Vivelle-Dot™ product
– the smallest estrogen patch in the world,
and the most dispensed estrogen patch
in the U.S. With the most advanced and
broadly applicable transdermal technology
in its class, Noven is committed to expanding
the universe of available transdermal
therapies for the benefit of patients,
partners and shareholders.